Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma

American Journal of Clinical Pathology

Volumn 126, Issue 2, 2006, Pages 284-293

  Elgui De Oliveira, Deilson ^a   Bacchi, Maura M ^c   Macarenco, Ricardo S S ^a   Tagliarini, José Vicente ^a   Cordeiro, Ricardo C ^b   Bacchi, Carlos E ^c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Botucatu School of Medicine UNESP ^*

Author keywords

EBV; Epstein Barr virus; HPV; Human papillomavirus; Laryngeal cancer; p53; Tumor growth fraction

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GRADING; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; EPSTEIN BARR VIRUS; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LARYNX CARCINOMA; LARYNX TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DNA, NEOPLASM; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; LARYNX; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33746683763     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/UU2JADUEHDWATVM9     Document Type: Article

References (50)

1. Yokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med. 1993;328:184-194.
2. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN. 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5. Lyon, France: IARC Press; 2001. Available at http://www-dep.iarc.fr/globocan/globocan. htm. Accessed May 26, 2004.
3. Licitra L, Bernier J, Grandi C, et al. Cancer of the larynx. Crit Rev Oncol Hematol. 2003;47:65-80.
4. Tyan YS, Liu ST, Ong WR, et al. Detection of Epstein-Barr-virus and human papillomavirus in head and neck tumors. J Clin Microbiol. 1993;31:53-56.
5. Glickman JN, Howe JG, Steitz JA. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol. 1988;62:902-911.
6. Weiss LM, Chen YY, Liu XF, et al. Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol. 1991;139:1259-1265.
7. Gown AM, Wever N, Battifora H. Microwave-based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem. 1993;1:256-266.
8. de Roda Husman AM, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995;76(pt 4):1057-1062.
9. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:487-491.
10. Soler C, Allibert P, Chardonnet Y, et al. Detection of human papillomavirus types 6, 11, 16 and 18 in mucosal and cutaneous lesions by the multiplex polymerase chain reaction. J Virol Methods. 1991;35:143-157.
11. van den Brule AJ, Meijer CJ, Bakels V, et al. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol. 1990;28:2739-2743.
12. Cattaruzza MS, Maisonneuve P, Boyle P. Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol. 1996;32B:293-305.
13. Agudelo D, Quer M, Leon X, et al. Laryngeal carcinoma in patients without a history of tobacco and alcohol use. Head Neck. 1997;19:200-204.
14. Hirvikoski P, Virtaniemi J, Kumpulainen E, et al. Supraglottic and glottic carcinomas: clinically and biologically distinct entities? Eur J Cancer. 2002;38:1717-1723.
15. Rees L, Birchall M, Bailey M, et al. A systematic review of case-control studies of human papillomavirus infection in laryngeal squamous cell carcinoma. Clin Otolaryngol. 2004;29:301-306.
16. Gillison ML, Lowy DR. A causal role for human papillomavirus in head and neck cancer. Lancet. 2004;363:1488-1489.
17. Mao L, Hong WK. How does human papillomavirus contribute to head and neck cancer development? J Natl Cancer Inst. 2004;96:978-980.
18. Capone RB, Pai SI, Koch WM, et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res. 2000;6:4171-4175.
19. Watts SL, Brewer EE, Fry TL. Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surg Oral Med Oral Pathol. 1991;71:701-707.
20. Poljak M, Gale N, Kambic V. Human papillomaviruses: a study of their prevalence in the epithelial hyperplastic lesions of the larynx. Acta Otolaryngol Suppl. 1997;527:66-69.
21. Garcia-Milian R, Hernandez H, Panade L, et al. Detection and typing of human papillomavirus DNA in benign and malignant tumours of laryngeal epithelium. Acta Otolaryngol. 1998;118;754-758.
22. Matzow T, Boysen M, Kalantari M, et al. Low detection rate of HPV in oral and laryngeal carcinomas. Acta Oncol. 1998;37:73-76.
23. Miguel RE, Villa LL, Cordeiro AC, et al. Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer. Am J Surg. 1998;176:428-429.
24. Soto Y, Valdes C, Mune M, et al. Detection of type 16 human papillomavirus DNA in formalin-fixed invasive squamous cells from laryngeal cancers by polymerase chain reaction. Mem Inst Oswaldo Cruz. 1998;93:439-440.
25. Pintos J, Franco EL, Black MJ, et al. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract. Cancer. 1999;85:1903-1909.
26. Badaracco G, Venuti A, Morello R, et al. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res. 2000;20:1301-1305.
27. Jacob SE, Sreevidya S, Chacko E, et al. Cellular manifestations of human papillomavirus infection in laryngeal tissues. J Surg Oncol. 2002;79:142-150.
28. Aaltonen LM, Rihkanen H, Vaheri A. Human papillomavirus in larynx. Laryngoscope. 2002;112:700-707.
29. Pou AM, Rimell FL, Jordan JA, et al. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol. 1995;104(10 pt 1):758-762.
30. Fouret P, Martin F, Flahault A, et al. Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol. 1995;4:122-127.
31. Nishioka S, Fukushima K, Nishizaki K, et al. Human papillomavirus as a risk factor for head and neck cancers: a case-control study. Acta Otolaryngol Suppl. 1999;540:77-80.
32. Stubenrauch F, Laimins LA. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol. 1999;9:379-386.
33. Lung ML, Lam WK, So SY, et al. Evidence that respiratory tract is major reservoir for Epstein-Barr virus. Lancet. 1985;1:889-892.
34. Liavaag PG, Cheung RK, Kerrebijn JD, et al. The physiologic reservoir of Epstein-Barr virus does not map to upper aerodigestive tissues. Laryngoscope. 1998;108(1 pt 1):42-46.
35. Babcock GJ, Decker LL, Volk M, et al. EBV persistence in memory B cells in vivo. Immunity. 1998;9:395-404.
36. Jin YT, Kayser S, Kemp BL, et al. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer. 1998;82:2159-2165.
37. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993;53:4477-4480.
38. Olshan AF, Weissler MC, Pei H, et al. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra. Cancer Epidemiol Biomarkers Prev. 1997;6:499-504.
39. Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Res. 1992;52:5997-6000.
40. Gale N, Zidar N, Kambic V, et al. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx. Acta Otolaryngol Suppl. 1997;527:105410.
41. Lavieille JP, Brambilla E, Riva-Lavieille C, et al. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol. 1995;115:334-339.
42. Narayana A, Vaughan AT, Gunaratne S, et al. Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer. 1998;82:286-291.
43. Logullo AF, Kowalski LP, Nonogaki S, et al. p53 overexpression in epidermoid carcinoma of the head and neck. São Paulo Med J. 1997;115:1349-1355.
44. Brachman DG, Graves D, Vokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res. 1992;52:4832-4836.
45. Fouret P, Dabit D, Sibony M, et al. Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx. Am J Pathol. 1995;146:599-604.
46. Braakhuis BJ, Snijders PJ, Keune WJ, et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst. 2004;96:998-1006.
47. Suzuki T, Tsutsumi K, Nakajima T, et al. Spontaneous mutation of p53 gene in human papillomavirus type 16 E7-immortalized human laryngeal epithelial cells. Acta Otolaryngol Suppl. 1996;522:94-98.
48. van den Brekel MW, Bindels EM, Balm AJ. Prognostic factors in head and neck cancer. Eur J Cancer. 2002;38:1041-1043.
49. Krecicki T, Jelen M, Zalesska-Krecicka M, et al. Ki-67 immunostaining and prognosis in laryngeal cancer. Clin Otolaryngol. 1998;23:539-542.
50. Krecicki T, Jelen M, Zalesska-Krecicka M, et al. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. Oral Oncol. 1999;35:180-186.